Because GLP-1 medications suppress appetite and reduce total food intake, meeting this protein target requires deliberate planning
Phase 2 reported no increase in serious cardiovascular events
Mass spectra were acquired on an ultraflex III MALDI-TOF/TOF mass spectrometer (Bruker Daltonics) operating in reflective positive mode
The GLP-1 receptor agonist exenatide ameliorates neuroinflammation, locomotor activity, and anxiety-like behavior in mice with diet-induced obesity through the modulation of microglial M2 polarization and downregulation of SR-A4
C/EBP, CCAAT/enhancer binding protein
Optimal gut health also influences how the body stores and utilises fat, promoting its breakdown and preventing excessive accumulation. By maintaining a diet rich in fibre, fermented foods and prebiotics, individuals can support their gut health and improve their weight management efforts